Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Pfisterer et al., 2017
While the treatment with Ru(II)-OH or NP2 slightly elevated the ROS levels inside the hypoxic cancer cells, the treatment with NP4 showed a strong enhancement of ROS
Available from: Zelniker TA, Wiviott SD, Raz I, et al
10 archived snapshots Jun 2025: $1,100 (archived) Jul 2025: $1,100 (archived) Sep 2025: $1,100 (archived) Oct 2025: $1,100 (archived) Nov 2025: $1,100 (archived) Dec 2025: $1,100 (archived) Jan 2026: $1,100 (archived) Feb 2026: $1,100 (archived) Mar 2026: $1,100 (archived) May 2026: $1,100 (archived) Found publishes branded reference prices, not a program all-in
Lack of FDA Approval and Regulation One of the most pressing issues with BPC-157 is its lack of approval by the Food and Drug Administration (FDA)
US$ 25.27
US$ 20.96
US$ 29.69
US$ 21.35
US$ 24.23
US$ 27.62
US$ 24.39
:max_bytes(150000):strip_icc()/Health-GettyImages-2188682706-0e96ad748efc48a392eab3a7e2ccb4bf.jpg)
US$ 26.93
